Rifaximin

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9877953
SERIAL NO

15223383

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Amorphous rifaximin, methods of making it, and pharmaceutical compositions containing it. Also described are methods of converting amorphous rifaximin to crystalline rifaximin and vice versa.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CIPLA LIMITEDMUMBAI 400 013

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ghagare, Maruti Thane, IN 12 71
Kankan, Rajendra Narayanrao Mumbai, IN 103 239
Phull, Manjinder Singh Mumbai, IN 27 100
Rao, Dharmaraj Ramachandra Thane, IN 111 255

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 30, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 30, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00